Second-Line Diabetes Drugs and Cardiovascular Risks

Cardiovascular disease is the leading cause of morbidity and mortality in type 2 diabetes. Metformin is used widely as first-line therapy and may have cardiovascular benefits, but if patients can’t tolerate metformin or don’t achieve adequate glycemic control with it, there’s no consensus about second-line treatment.

Source: Second-Line Diabetes Drugs and Cardiovascular Risks